scispace - formally typeset
W

William A. Blattner

Researcher at University of Maryland, Baltimore

Publications -  345
Citations -  26953

William A. Blattner is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Population & Virus. The author has an hindex of 80, co-authored 345 publications receiving 26023 citations. Previous affiliations of William A. Blattner include RTI International & Boston University.

Papers
More filters
Journal ArticleDOI

Incidence of lymphomas and other cancers in HIV-infected and HIV-uninfected patients with hemophilia.

TL;DR: HIV infection has restricted effects on cancer incidence that is only partly explained by immunosuppression, and improvements in therapy of HIV infection that prolong survival may lead to further increases in HIV-associated lymphoma.
Journal ArticleDOI

Quantitative Proviral DNA and Antibody Levels in the Natural History of HTLV-I Infection

TL;DR: The virologic correlates of infection in transfusion recipients after seroconversion, in asymptomatic carriers, and in ATL and HAM/TSP patients were evaluated to find proviral load and antibody titers may be useful as predictive markers of disease among carriers.
Journal ArticleDOI

The human T-cell leukemia/lymphoma virus, lymphoma, lytic bone lesions, and hypercalcemia.

TL;DR: Patients with adult peripheral T-cell lymphomas, particularly those that present with hypercalcemia and lytic bone lesions, may have antibodies to the type C RNA human tumor virus, HTL virus.
Journal ArticleDOI

Development and early natural history of HTLV-III antibodies in persons with hemophilia.

TL;DR: The long latency period after seroconversion suggests an ongoing indolent process, rather than an acute infection in seropositive patients with hemophilia, and it remains to be determined whether this is an aberrant part of the immune response initiated by HTLV-III antigens or the result of a chronic active HTLV
Journal Article

Mother-to-child transmission of human T-cell lymphotropic virus type I associated with prolonged breast-feeding.

TL;DR: It is suggested that limiting the duration of breast-feeding to less than 12 months for children born to HTLV-I-seropositive mothers may significantly reduce mother-to-child transmission of HTLV -I.